Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Fortress Biotech (FBIO) Asset Utilization Ratio (2016 - 2025)

Fortress Biotech has reported Asset Utilization Ratio over the past 11 years, most recently at 0.36 for Q4 2025.

  • For Q4 2025, Asset Utilization Ratio fell 12.47% year-over-year to 0.36; the TTM value through Dec 2025 reached 0.36, down 12.47%, while the annual FY2025 figure was 0.38, 8.47% up from the prior year.
  • Asset Utilization Ratio for Q4 2025 was 0.36 at Fortress Biotech, up from 0.35 in the prior quarter.
  • Over five years, Asset Utilization Ratio peaked at 0.61 in Q3 2024 and troughed at 0.05 in Q1 2021.
  • A 5-year average of 0.23 and a median of 0.18 in 2022 define the central range for Asset Utilization Ratio.
  • Biggest five-year swings in Asset Utilization Ratio: plummeted 127.63% in 2021 and later soared 1742.73% in 2022.
  • Year by year, Asset Utilization Ratio stood at 0.16 in 2021, then fell by 15.8% to 0.13 in 2022, then skyrocketed by 148.25% to 0.33 in 2023, then rose by 22.18% to 0.41 in 2024, then dropped by 12.47% to 0.36 in 2025.
  • Business Quant data shows Asset Utilization Ratio for FBIO at 0.36 in Q4 2025, 0.35 in Q3 2025, and 0.34 in Q2 2025.